Results 161 to 170 of about 15,916,923 (300)

Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues

, 2006
Relapse to drug use is frequently preceded or caused by craving, an intense desire for drug. Advances in functional brain imaging techniques make it possible to directly investigate this special mental state in vivo and non-invasively.
Z. W. Xiao, Wu, RH, Zhang, JX, Weng, XC, Wu, QL, Lee, T, Hu, XP, Xiao, ZW   +7 more
core  

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

Advanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang, Jianhua Li, Huilu Zhang, Qi Qin, Yichen Huang, Xiaofan Tian, Chao Sun, Binbin Li, Zhengxin Wang, Xin Zhang   +9 more
wiley   +1 more source

Drug-related problems and their predictors in pediatric community-acquired infections: the role of pharmacist-led interventions in Pakistan. [PDF]

J Pharm Pharm Sci
Ali S, Zehra A, Anjum F, Shah SSAM, Abro F, Shakeel S, Ali M.   +6 more
europepmc   +1 more source

A Review on Catalytic Nanostructured Electrodes for Wearable and Implantable Abiotic Glucose Fuel Cells

Advanced Science, EarlyView.
This review identifies current and future directions in abiotic nanostructured catalysts to develop reliable and sustainable glucose fuel cells to power the next generation of bioelectronic devices. ABSTRACT The global rise in incidence of chronic diseases has led to the demand for innovative solutions that help patients manage their conditions with ...
Asghar Niyazi, Hannah S. Leese, Benjamin Metcalfe, Mirella Di Lorenzo   +3 more
wiley   +1 more source

Patients' Needs and Expectations for the Application of Prevention of Drug-related Problems Prevention Programs. [PDF]

J Res Pharm Pract
Llopis AV, Ruiz-Ramos J, Díaz AP, Campmany MP, Álvarez AB, Sampol-Mayol C, Juanes-Borrego A.   +6 more
europepmc   +1 more source

Atomic Defects in Layered Transition Metal Dichalcogenides for Sustainable Energy Storage and the Intelligent Trends in Data Analytics

Advanced Science, EarlyView.
This review comprehensively summarizes the atomic defects in TMDs for their applications in sustainable energy storage devices, along with the latest progress in ML methodologies for high‐throughput TEM data analysis, offering insights on how ML‐empowered microscopy facilitates bridging structure–property correlation and inspires knowledge for precise ...
Zheng Luo, Ying Yang, Zizhen Fu, Fengqi Liu, Susu Fang, Kele Xu, Shanshan Wang   +6 more
wiley   +1 more source

Nephrotoxic medication burden and drug-related problems in patients with chronic kidney disease using SGLT2 inhibitors. [PDF]

Ren Fail
Ozturk Yalcin Z, Erdut A, Haberal G, Arici M, Bayraktar-Ekincioglu A.   +4 more
europepmc   +1 more source

Problems in responding to co-occurring mental health and drug related problems - a criminal justice perspective

, 2008
Problems in responding to co-occurring mental health and drug related problems - a criminal justice ...
K Howells (9885422), A Day (7994972)
core  

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Development and evaluation of an e-learning program on drug-related problems for community pharmacists. [PDF]

Int J Clin Pharm
Vogt CJ, Reuther A, Wurmbach VS, Weißenborn M, Bittmann JA, Wien K, Lampert A, Eknes EMB, Schäfer P, Seidling HM.   +9 more
europepmc   +1 more source